On January 2, 2024, Bioleaders Corporation closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,845 KRW | +0.39% | +14.78% | +80.52% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,840 KRW | +0.88% | +1.18% | 197M | ||
3,845 KRW | +0.39% | +14.78% | 91.09M | ||
1st Jan change | Capi. | |
---|---|---|
+80.52% | 91.09M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- A142760 Stock
- News MOA Life Plus Co. Ltd.
- Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.